2don MSN
Legal questions swirl around FDA’s new expedited drug program, including who should sign off
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
Martin Makary, commissioner of the Food and Drug Administration, on the push against ultra processed foods and added sugar, ...
The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
The U.S. Food and Drug Administration has delayed reviews of several drugs selected for the Trump administrations new ...
GlobalData on MSN
FDA prevails over EMA in 2025 novel drug approvals
This is eight fewer than the FDA, which approved 46 novel drugs in 2025 – sneaking in two regulatory decisions during the ...
Drug manufacturers' use of AI has recently increased significantly, according to the FDA. Here's how the agency says the ...
3don MSN
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
— Novel, third-generation PCSK9 inhibitor designed to help patients more easily achieve lifelong cholesterol goals with robust and sustained LDL-C reductions of 50% or more — — Approved for adults ...
Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like Wegovy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback